Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.55 USD | -3.79% | -14.87% | -85.71% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.71% | 124M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.14% | 22.58B | |
-14.41% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- JPMorgan Lowers RAPT Therapeutics' Price Target to $13 From $15, Keeps Neutral Rating